Mirati Therapeutics (MRTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
58.70 -0.10 (-0.17%) 01/22/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 58.70 unch (unch) -
for Mon, Jan 22nd, 2024
Results
download Want to compare other data? Select FieldsSymbol | MRTX | RYTM | PTCT | ||
Company | Mirati Therapeutics | Rhythm Pharmaceuticals Inc | Ptc Therapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 58.86 | 64.40 | 49.27 | ||
High | 58.99 | 65.58 | 50.33 | ||
Low | 58.54 | 63.81 | 48.44 | ||
Last | 58.70 | 65.19 | 49.84 | ||
Change | -0.10 | -0.03 | +0.32 | ||
% Change | -0.17% | -0.05% | +0.65% | ||
Volume | 20,994,400 | 402,200 | 1,206,600 | ||
20-Day Average Volume | 2,385,220 | 983,030 | 1,101,285 | ||
Previous Close | 58.80 | 65.22 | 49.52 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 58.94 | 59.27 | 46.36 | ||
20-Day Raw Stochastic | 17.39% | 98.02% | 94.28% | ||
20-Day Relative Strength | 61.06% | 62.60% | 52.13% | ||
Weighted Alpha | -3.70 | +24.59 | +49.25 | ||
Today's Opinion | 88% Buy | 72% Buy | 40% Buy | ||
Previous Opinion | 88% Buy | 72% Buy | 40% Buy | ||
Last Month's Opinion | 100% Buy | 8% Sell | 64% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -0.98% since 01/12/24 | +8.94% since 04/23/25 | -0.22% since 04/23/25 | ||
Low | 58.54 on 01/22/24 | 59.78 on 04/24/25 | 48.09 on 04/25/25 | ||
High | 59.27 on 01/16/24 | 65.58 on 04/30/25 | 50.40 on 04/28/25 | ||
1-Month | |||||
%Chg | -0.41% since 12/22/23 | +18.96% since 03/28/25 | -8.11% since 03/28/25 | ||
Low | 58.54 on 01/22/24 | 45.90 on 04/07/25 | 37.32 on 04/09/25 | ||
High | 59.46 on 01/12/24 | 65.58 on 04/30/25 | 52.89 on 03/31/25 | ||
3-Month | |||||
%Chg | +5.42% since 10/20/23 | +10.08% since 01/30/25 | +8.00% since 01/30/25 | ||
Low | 55.14 on 10/27/23 | 45.90 on 04/07/25 | 37.32 on 04/09/25 | ||
High | 59.46 on 01/12/24 | 65.58 on 04/30/25 | 58.38 on 03/17/25 | ||
6-Month | |||||
%Chg | +87.48% since 07/21/23 | +31.59% since 10/30/24 | +22.58% since 10/30/24 | ||
Low | 27.30 on 08/08/23 | 45.90 on 04/07/25 | 37.32 on 04/09/25 | ||
High | 64.41 on 10/06/23 | 68.58 on 11/11/24 | 58.38 on 03/17/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 4,117,688 | 4,123,469 | 3,905,593 | ||
Shares Outstanding, K | 70,148 | 63,224 | 78,869 | ||
Annual Sales | 12,440,000 | 130,130,000 | 806,780,000 | ||
Annual Net Income | -740,870,000 | -260,600,000 | -363,300,000 | ||
Last Quarter Sales | 16,400,000 | 41,830,000 | 213,170,000 | ||
Last Quarter Net Income | -161,900,000 | -43,330,000 | -65,890,000 | ||
60-Month Beta | 0.77 | 2.32 | 0.58 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.49 on 11/06/23 | -0.72 on 02/26/25 | -0.24 on 02/27/25 | ||
Latest Earnings Date | 02/27/24 | 05/07/25 | 05/06/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |